Join Business Exchange
to access the mostrelevant content for you,
filtered by like-mindedbusiness professionals.
LOS ANGELES (MarketWatch) �� U.S.-listed shares of GlaxoSmithKline Plc rose Tuesday evening following reports that a regulatory panel has recommended for approval the drugmaker��s jointly development treatment for lupus. Glaxo shares...
to access the most relevant content for you, filtered by like-minded business professionals.
About Business Exchange
Send us Feedback
©2013 Bloomberg L.P. All Rights Reserved.